Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Lee Kaplan
Massachusetts General Hospital, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Rhythm Pharmaceuticals
Payment for services (e.g., consulting fees, honoraria, paid authorship)
Rhythm Pharmaceuticals develops a MC4R antagonist for the treatment of rare genetic disorders of obesity. Dr. Kaplan is the Associate Director of the Nutrition Obesity Research Center at Harvard with responsibility over the administration and management of this grant. The grant supports a large base of investigators throughout the Harvard system who are engaged in research in the fields of nutrition and obesity, including genetic disorders of obesity. In this role, Dr. Kaplan serves as a member of the committee that selects which research projects will be funded under this grant. Because the research conducted under the grant and the company focus on obesity and related disorders, the results of the studies supported by the grant could be of interest to the companies. The Partners Committee on Outside Activities review panel evaluated the financial interests in connection with this grant and determined that, based on the close connection between the companies' interests and the research supported by the grant, the financial interests could directly and significantly affect Dr. Kaplan’s grant administration activities.
Nutrition Obesity Research Center at Harvard
Project Narrative The Nutrition Obesity Research Center at Harvard (NORC-H) supports a large base of investigators throughout the Harvard system who are engaged in research in the fields of nutrition and obesity and who have made substantial contributions to these fields. The NORC-H fosters community and collaboration among these researchers and provides critical support to both senior and junior investigators in the form of Core services, Pilot and Feasibility Grants, statistical support, and opportunities to share and disseminate research findings.
Filed on October 31, 2017.
Tell us what you know about Lee Kaplan's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Lee Kaplan”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Lee Kaplan | Massachusetts General Hospital | Conflict of Interest | Fractyl Laboratories, Inc. | Value cannot be readily determined |
| Lee Kaplan | Massachusetts General Hospital | Conflict of Interest | Rhythm Pharmaceuticals | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.